title: FDA's advisers recommend updating alosetron's REMS.
authors.forename: Cheryl A
authors.initials: CA
authors.lastname: Thompson
mesh_terms: D002243:Carbolines / Q000009:adverse effects*; D055695:Electronic Prescribing; D006801:Humans; D008508:Medication Errors / Q000517:prevention & control*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D002243:Carbolines; C090840:alosetron